Abstract
To prevent persistent neurodevelopment and physical growth deficits in neonatal care, it is mandatory to determine blood glucose levels as quickly and precisely as possible, preferably using micro-methods. However, most commercially available instruments have not been validated and approved for this purpose. The aim of this study was to validate the Glucometer Elite XL, a newly developed device for point-of-care testing (POCT). In samples from 869 newborn infants, glucose levels were simultaneously measured by the Glucometer Elite XL in whole blood and by an accepted clinical laboratory method in haemolysed blood using the ECA 2000 device. An acceptable method agreement was found between the POCT and the ECA 2000 method (mean difference 0.013 mmol/l, SD 0.69). As determined by regression analysis (Passing-Bablok), the slope was 1.086 with a y-intercept of −0.4 mmol/l ( r =0.959, P <0.05). The differences between measurement pairs of both assays versus the haematocrit were negligible. With a cut-off for hypoglycaemia at 2.6 mmol/l glucose in haemolysed blood, the sensitivity of the POCT device was 0.63 and specificity was 0.98. Raising the cut-off of the Glucometer Elite XL to 3.2 mmol/l, the sensitivity and specificity incremented to 1.0 and 0.89, respectively. Conclusion:The Glucometer Elite XL instrument can be recommended for point-of-care blood glucose measurement in newborn infants if its character as a screening method is taken into account. To compensate deviating results, we advise to shift its cut-off for hypoglycaemia recognition to a safe threshold of 3.2 mmol/l. However, hypoglycaemia has to be confirmed by a valid glucose measurement in the clinical laboratory.
Similar content being viewed by others
Abbreviations
- CV :
-
coefficient of variation
- POCT :
-
point-of-care testing
- ROC :
-
receiver operating characteristics
References
Bekefi D, Szolnoki J, Koranyi J, Ferencz A (1984) Reflectometric blood glucose determination in the neonatological intensive care: haematocrit dependence. Exp Clin Endocrinol 83: 178–183
Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC (2000) Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics 105: 1141–1145
Cowett RM, Loughead JL (2002) Neonatal glucose metabolism: differential diagnoses, evaluation, and treatment of hypoglycemia. Neonatal Netw 21: 9–19
Cowett RM, Howard GM, Johnson J, Vohr B (1997) Brain stem auditory-evoked response in relation to neonatal glucose metabolism. Biol Neonate 71: 31–36
Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Matthieu JM (1999) Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr 134: 492–498
Girouard J, Forest JC, Masse J, Leroux M, Bradburn NC, Noblet TC, Joynes JO, Baum J (2000) Multicenter evaluation of the Glucometer Elite XL meter, an instrument specifically designed for use with neonates. Diabetes Care 23: 1149–1153
Gregory JW, Aynsley-Green A (1993) The definition of hypoglycaemia. Baillieres Clin Endocrinol Metab 7: 587–590
Ho HT, Yeung WK, Young BW (2004) Evaluation of “point of care” devices in the measurement of low blood glucose in neonatal practice. Arch Dis Child Fetal Neonatal Ed 89: F356–F359
Holtrop PC, Madison KA, Kiechle FL, Karcher RE, Batton DG (1990) A comparison of chromogen test strip (Chemstrip bG) and serum glucose values in newborns. Am J Dis Child 144: 183–185
Innanen VT, DeLand ME, de Campos FM, Dunn MS (1997) Point-of-care glucose testing in the neonatal intensive care unit is facilitated by the use of the Ames Glucometer Elite electrochemical glucose meter. J Pediatr 130: 151–155
Leibundgut KE, Bucher HU, Mieth D, Duc G (1989) Clinical assessment of a new glucose reflectance meter (Glucoscot II) for the detection of neonatal hypoglycemias. Monatsschr Kinderheilkd 137: 330–332
Leonard M, Chessall M, Manning D (1997) The use of a Hemocue blood glucose analyser in a neonatal unit. Ann Clin Biochem 34: 287–290
Lucas A, Morley R, Cole TJ (1988) Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 297: 1304–1308
Mehta A (1994) Prevention and management of neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed 70: F54–F59
Meloy L, Miller G, Chandrasekaran MH, Summitt C, Gutcher G (1999) Accuracy of glucose reflectance testing for detecting hypoglycemia in term newborns. Clin Pediatr (Phila) 38: 717–724
Sacks DB (1999) Carbohydrates, specimen collection and storage. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry. Saunders, Philadelphia, pp 777
Schlebusch H, Niesen M, Sorger M, Paffenholz I, Fahnenstich H (1998) Blood glucose determinations in newborns: four instruments compared. Pediatr Pathol Lab Med 18: 41–48
Thomas CL, Critchley L, Davies MW (2000) Determining the best method for first-line assessment of neonatal blood glucose levels. J Paediatr Child Health 36: 343–348
Acknowledgements
We are grateful to all infants and their parents who took part in the study as well as to all nurses and doctors for their assistance. The study was supported by Bayer Diagnostics, Munich, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Michel, A., Küster, H., Krebs, A. et al. Evaluation of the Glucometer Elite XL device for screening for neonatal hypoglycaemia. Eur J Pediatr 164, 660–664 (2005). https://doi.org/10.1007/s00431-005-1733-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-005-1733-9